BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32569076)

  • 1. Reduction in Alveolar Macrophage Size in Refractory Autoimmune Pulmonary Alveolar Proteinosis After Treatment With Pioglitazone.
    Vis DC; Kelly MM; De Heuvel E; MacEachern PR
    J Bronchology Interv Pulmonol; 2020 Jul; 27(3):219-222. PubMed ID: 32569076
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R
    Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary alveolar proteinosis: a new autoimmune disease.
    Costabel U; Guzman J
    Sarcoidosis Vasc Diffuse Lung Dis; 2005 Dec; 22 Suppl 1():S67-73. PubMed ID: 16457018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
    Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
    Kavuru MS; Malur A; Marshall I; Barna BP; Meziane M; Huizar I; Dalrymple H; Karnekar R; Thomassen MJ
    Eur Respir J; 2011 Dec; 38(6):1361-7. PubMed ID: 21478218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
    Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
    Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary Alveolar Proteinosis Syndrome.
    Suzuki T; Trapnell BC
    Clin Chest Med; 2016 Sep; 37(3):431-40. PubMed ID: 27514590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Serum Anti-GM-CSF Antibodies before the Onset of Autoimmune Pulmonary Alveolar Proteinosis in a Patient with Sarcoidosis and Systemic Sclerosis.
    Yamasue M; Nureki SI; Usagawa Y; Ono T; Matsumoto H; Kan T; Kadota JI
    Tohoku J Exp Med; 2017 Sep; 243(1):77-83. PubMed ID: 28966213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral peripheral infiltrates refractory to immunosuppressants were diagnosed as autoimmune pulmonary alveolar proteinosis and improved by inhalation of granulocyte/macrophage-colony stimulating factor.
    Satoh H; Tazawa R; Sakakibara T; Ohkouchi S; Ebina M; Miki M; Nakata K; Nukiwa T
    Intern Med; 2012; 51(13):1737-42. PubMed ID: 22790136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light chain (κ/λ) ratio of GM-CSF autoantibodies is associated with disease severity in autoimmune pulmonary alveolar proteinosis.
    Nei T; Urano S; Itoh Y; Kitamura N; Hashimoto A; Tanaka T; Motoi N; Kaneko C; Tazawa R; Nakagaki K; Arai T; Inoue Y; Nakata K
    Clin Immunol; 2013 Dec; 149(3):357-64. PubMed ID: 24211842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune Pulmonary Alveolar Proteinosis: Evidence of the Pathogenicity of GM-CSF Antibodies.
    Le Gal A; Chabrol A; Brun AL; Fraboulet S; Couderc LJ; Salvator H
    Am J Respir Crit Care Med; 2021 Dec; 204(12):e134-e135. PubMed ID: 34129433
    [No Abstract]   [Full Text] [Related]  

  • 12. Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis.
    Sakagami T; Uchida K; Suzuki T; Carey BC; Wood RE; Wert SE; Whitsett JA; Trapnell BC; Luisetti M
    N Engl J Med; 2009 Dec; 361(27):2679-81. PubMed ID: 20042763
    [No Abstract]   [Full Text] [Related]  

  • 13. Autoimmune Pulmonary Alveolar Proteinosis Complicated with Sarcoidosis: the Clinical Course and Serum Levels of Anti-granulocyte-macrophage colony-stimulating Factor Autoantibody.
    Arai T; Kasai T; Shimizu K; Kawahara K; Katayama K; Sugimoto C; Hirose M; Okamoto H; Tachibana K; Akira M; Inoue Y
    Intern Med; 2020 Oct; 59(20):2539-2546. PubMed ID: 32611952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Trapnell BC; Terakawa T; Hamano E; Mikami A; Matsushita I; Seymour JF; Oh-Eda M; Ishige I; Eishi Y; Kitamura T; Yamada Y; Hanaoka K; Keicho N
    Blood; 2004 Feb; 103(3):1089-98. PubMed ID: 14512323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune Pulmonary Alveolar Proteinosis Following Pulmonary Aspergillosis.
    Arai T; Inoue Y; Akira M; Nakata K; Kitaichi M
    Intern Med; 2015; 54(24):3177-80. PubMed ID: 26666607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary alveolar proteinosis.
    Trapnell BC; Whitsett JA; Nakata K
    N Engl J Med; 2003 Dec; 349(26):2527-39. PubMed ID: 14695413
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary alveolar proteinosis successfully treated with ambroxol.
    Hashizume T
    Intern Med; 2002 Dec; 41(12):1175-8. PubMed ID: 12521210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential Granulocyte-Macrophage Colony-Stimulating Factor Inhalation after Whole-Lung Lavage for Pulmonary Alveolar Proteinosis. A Report of Five Intractable Cases.
    Ohkouchi S; Akasaka K; Ichiwata T; Hisata S; Iijima H; Takada T; Tsukada H; Nakayama H; Machiya JI; Irokawa T; Ogawa H; Shibata Y; Ichinose M; Ebina M; Nukiwa T; Kurosawa H; Nakata K; Tazawa R
    Ann Am Thorac Soc; 2017 Aug; 14(8):1298-1304. PubMed ID: 28421817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occupational inhalational exposure and serum GM-CSF autoantibody in pulmonary alveolar proteinosis.
    Xiao YL; Xu KF; Li Y; Li Y; Li H; Shi B; Zhou KF; Zhou ZY; Cai HR
    Occup Environ Med; 2015 Jul; 72(7):504-12. PubMed ID: 25995295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [autoimmune pulmonary alveolar proteinosis and GM-CSF inhalation therapy].
    Tazawa R; Nakata K
    Nihon Yakurigaku Zasshi; 2011 Aug; 138(2):64-7. PubMed ID: 21828940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.